1-(tert-Butoxycarbonyl)-3-methylpyrrolidine-3-carboxylic acid
90%
- Product Code: 39578
CAS:
887587-09-9
| Molecular Weight: | 229.27 g./mol | Molecular Formula: | C₁₁H₁₉NO₄ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD15071411 | |
| Melting Point: | Boiling Point: | 337.8±35.0°C at 760 mmHg | |
| Density: | Storage Condition: | 2-8°C, dry and sealed |
Product Description:
This compound is primarily used in organic synthesis, particularly in the preparation of pharmaceuticals and bioactive molecules. It serves as a key intermediate in the development of compounds with potential therapeutic applications, such as inhibitors or modulators of specific biological targets. Its tert-butoxycarbonyl (Boc) protecting group is crucial in peptide synthesis, allowing for selective deprotection and subsequent reactions without affecting other functional groups. Additionally, its structure makes it valuable in the design of novel drugs targeting neurological or metabolic disorders, where the pyrrolidine ring can enhance binding affinity and selectivity.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White Solid |
| PURITY | 89.5-100 |
| Infrared spectrum | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿3,600.00 |
+
-
|
| 0.250 | 10-20 days | ฿6,800.00 |
+
-
|
| 1.000 | 10-20 days | ฿16,800.00 |
+
-
|
1-(tert-Butoxycarbonyl)-3-methylpyrrolidine-3-carboxylic acid
This compound is primarily used in organic synthesis, particularly in the preparation of pharmaceuticals and bioactive molecules. It serves as a key intermediate in the development of compounds with potential therapeutic applications, such as inhibitors or modulators of specific biological targets. Its tert-butoxycarbonyl (Boc) protecting group is crucial in peptide synthesis, allowing for selective deprotection and subsequent reactions without affecting other functional groups. Additionally, its structure makes it valuable in the design of novel drugs targeting neurological or metabolic disorders, where the pyrrolidine ring can enhance binding affinity and selectivity.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :